Transcranial Magnetic Stimulation (TMS) is now available for adolescents as young as 15, and insurance providers like Aetna are expanding their coverage to meet this growing demand. As of now, Aetna has updated their policies to cover TMS for adolescents aged 15 and older with Major Depressive Disorder (MDD), but this shift is…
September is Suicide Prevention Month in the U.S., a time to raise awareness about a crisis that affects millions of individuals and families. Suicide is the 10th leading cause of death in the country, with mental health challenges like depression playing a significant role in many cases. As a community, we must come…
Transcranial Magnetic Stimulation (TMS) has rapidly become one of the most effective treatments for depression and other mental health conditions. As its popularity grows, many clinic owners are asking themselves: how profitable is TMS, and what’s the best device to maximize that profit? The Growing Demand for TMS TMS is in high demand…
The landscape of mental health treatment is rapidly evolving, and Transcranial Magnetic Stimulation (TMS) is at the forefront of this transformation. Traditionally used as a secondary or last-resort treatment for individuals who did not respond to antidepressant medications, TMS is now being considered a first-line treatment option for depression by many psychiatrists and…
Since the FDA approved the 10 Hz transcranial magnetic stimulation (TMS) protocol in 2008, this groundbreaking treatment has offered relief to tens of thousands of patients suffering from treatment-resistant depression worldwide. The 10 Hz protocol, targeting the left dorsolateral prefrontal cortex (DLPFC), has become a cornerstone of non-invasive brain stimulation therapies. Despite the advent of…
Exploring the Journey of Insurance Coverage for Transcranial Magnetic Stimulation in the USA Transcranial Magnetic Stimulation (TMS) has emerged as a revolutionary treatment for various mental health conditions, offering hope to those who have not responded to traditional therapies. While the effectiveness of TMS has been well-documented, its accessibility has significantly hinged on…
When it comes to Transcranial Magnetic Stimulation (TMS), the technology behind the treatment is as critical as the therapy itself. At SEBERS Medical, we’ve taken every aspect of TMS therapy into consideration when designing the Blossom TMS device, ensuring it not only meets but exceeds the expectations of clinicians and patients alike. Here…
We are thrilled to announce that the digital version of our acclaimed Blossom Burst TMS magazine is now available online! You can access the latest issue directly at https://blossomtms.com/tms-blossom-burst-magazine/ This digital edition is packed with insightful articles, expert opinions, and the latest advancements in TMS technology and mental health care. What You Can Expect…
Excerpt from our magazine: This blog post is an excerpt from our magazine. For a free digital or print version to read the full article and much more, visit us at https://sebersmedical.com/ In the evolving landscape of psychiatric treatment, particularly in the realm of depression therapy, few names stand out as prominently as Dr.…
Phone: 833.3BUY.TMS (+1.833.3289.867)
Email: Sales@sebersmedical.com
Address: 230 S Broad Street, 17th Floor Philadelphia, PA 19102
Regulations in the United States
*United States Federal Law regulates the sale of Medical Devices. The Blossom TMS Therapy System is indicated for the treatment of Major Depressive Disorder in adult patients, who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. (K220625) All other devices on this website are not approved and/or cleared for use in treatment and/or diagnosis in the United States. All investigational devices must be labeled in accordance with the labeling requirements of the IDE regulation (§ 812.5) and bear a label that states:
“CAUTION.
Investigational Device. Restricted by federal (or United States) law to research use.”
© 2024 SEBERS MEDICAL
